A detailed history of Verition Fund Management LLC transactions in Liquidia Corp stock. As of the latest transaction made, Verition Fund Management LLC holds 14,107 shares of LQDA stock, worth $155,318. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,107
Holding current value
$155,318
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$11.96 - $15.71 $168,719 - $221,620
14,107 New
14,107 $169,000
Q3 2023

Nov 14, 2023

BUY
$6.27 - $8.15 $181,203 - $235,535
28,900 New
28,900 $183,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.